Researchers reported hopeful news on regimens with lower treatment burdens and newly developed antiretrovirals.
Steven Deeks, M.D., talks about the medical community's hopes, inspirations, and unanswered questions regarding research for an HIV cure.
World Health Organization Updates Guidance on Dolutegravir After Reassuring Data Regarding Safety in Early Pregnancy
New study results leave many experts feeling they went too far in their concerns over birth defect risks associated with the drug.
Having Fallen Out of Care, Most Gay and Bisexual Men With Detectable HIV Viral Loads Were Successfully Reconnected, Study Finds
The study enrolled more than a thousand people in four U.S. cities: Atlanta, Baltimore, Birmingham, and Boston.
Six thousand HIV researchers and experts are expected to make their way to Mexico City for the 10th International AIDS Society Conference on HIV Science, which will feature more than 1,000 abstracts highlighting the latest findings in HIV treatment, prevention, and public health policy.
Paul Sax, M.D., recaps dozens of highlights from 9th International AIDS Society Conference on HIV Science.
In the last two decades, antiretroviral therapy has dramatically improved the health of people living with HIV. Let’s take a brief look at the past and present before we look forward to HIV treatment in 2020.
Today, new classes of antiretrovirals, such as attachment inhibitors, continue to be developed, and synthetic versions of naturally occurring antibodies -- broadly neutralizing antibodies -- are being studied for both HIV treatment and prevention....
If you want to fight the HIV epidemic, you have to put your money where your mouth is.
Looking back on how far we have come, Julio Montaner, M.D., director of the British Columbia Centre for Excellence in HIV/AIDS says we now have the "irrefutable, conclusive, impeccable" proof that starting HIV treatment immediately after testing posi...